Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
21.8 NOK
−309.73 M NOK
2.14 B NOK
4.23 M
About AKER BIOMARINE ASA
Sector
Industry
CEO
Matts Eirik Johansen
Website
Headquarters
Lysaker
Founded
2013
ISIN
NO0010886625
FIGI
BBG01GN9P6Q9
Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. It operates through the Ingredients and Brands segments. The Ingredients segment includes offshore harvesting and production activities, logistical operations, and the onshore manufacturing and sale of krill oil products globally to distributors and feed producers. The Brands segment relates to the group legal entities Lang Pharma Nutrition LLC, Epion Brands LLC , and the holding company New Ride LLC. The company was founded in 2006 and is headquartered in Lysaker, Norway.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on AQUISEU exchange Aker Biomarine ASA stocks are traded under the ticker AKBMO.
We've gathered analysts' opinions on Aker Biomarine ASA future price: according to them, AKBMO price has a max estimate of 95.11 NOK and a min estimate of 49.95 NOK. Watch AKBMO chart and read a more detailed Aker Biomarine ASA stock forecast: see what analysts think of Aker Biomarine ASA and suggest that you do with its stocks.
AKBMO reached its all-time high on Sep 6, 2024 with the price of 109.6 NOK, and its all-time low was 33.5 NOK and was reached on Jun 15, 2023. View more price dynamics on AKBMO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Aker Biomarine ASA financials in yearly and quarterly reports right on TradingView.
Aker Biomarine ASA is going to release the next earnings report on Oct 31, 2025. Keep track of upcoming events with our Earnings Calendar.
AKBMO earnings for the last quarter are −1.72 NOK per share, whereas the estimation was −0.01 NOK resulting in a −24.22 K% surprise. The estimated earnings for the next quarter are 0.24 NOK per share. See more details about Aker Biomarine ASA earnings.
Aker Biomarine ASA revenue for the last quarter amounts to 557.14 M NOK, despite the estimated figure of 537.39 M NOK. In the next quarter, revenue is expected to reach 595.06 M NOK.
AKBMO net income for the last quarter is −151.41 M NOK, while the quarter before that showed −34.32 M NOK of net income which accounts for −341.15% change. Track more Aker Biomarine ASA financial stats to get the full picture.
As of Jul 21, 2025, the company has 249 employees. See our rating of the largest employees — is Aker Biomarine ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aker Biomarine ASA EBITDA is 279.60 M NOK, and current EBITDA margin is 8.54%. See more stats in Aker Biomarine ASA financial statements.
Like other stocks, AKBMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aker Biomarine ASA stock right from TradingView charts — choose your broker and connect to your account.